Golden Throat Holdings Group Company Limited (6896.HK)
HKD 4.18
(-0.24%)
HKD 4.18
(-0.24%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 412.34 Million CNY | 51.27% |
| 2022 | 272.58 Million CNY | 15.99% |
| 2021 | 234.99 Million CNY | 54.15% |
| 2020 | 152.45 Million CNY | 58.6% |
| 2019 | 96.12 Million CNY | 0.13% |
| 2018 | 96 Million CNY | 11.63% |
| 2017 | 86 Million CNY | 30.3% |
| 2016 | 66 Million CNY | -28.02% |
| 2015 | 91.69 Million CNY | -3.26% |
| 2014 | 94.78 Million CNY | -12.24% |
| 2013 | 108 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q4 | 412.34 Million CNY | 57.97% |
| 2023 FY | 412.34 Million CNY | 51.27% |
| 2023 Q2 | 261.03 Million CNY | -4.24% |
| 2022 Q4 | 272.58 Million CNY | -10.87% |
| 2022 FY | 272.58 Million CNY | 15.99% |
| 2022 Q2 | 305.81 Million CNY | 30.13% |
| 2021 Q4 | 234.99 Million CNY | 11.72% |
| 2021 FY | 234.99 Million CNY | 54.15% |
| 2021 Q2 | 210.34 Million CNY | 37.98% |
| 2020 Q4 | 152.45 Million CNY | -23.68% |
| 2020 Q2 | 199.74 Million CNY | 107.8% |
| 2020 FY | 152.45 Million CNY | 58.6% |
| 2019 FY | 96.12 Million CNY | 0.13% |
| 2019 Q2 | 355.82 Million CNY | 270.65% |
| 2019 Q4 | 96.12 Million CNY | -72.99% |
| 2018 Q4 | 96 Million CNY | -4.95% |
| 2018 FY | 96 Million CNY | 11.63% |
| 2018 Q2 | 101 Million CNY | 17.44% |
| 2017 Q4 | 86 Million CNY | -25.86% |
| 2017 FY | 86 Million CNY | 30.3% |
| 2017 Q2 | 116 Million CNY | 75.76% |
| 2016 Q2 | 203.12 Million CNY | 121.53% |
| 2016 Q4 | 66 Million CNY | -67.51% |
| 2016 FY | 66 Million CNY | -28.02% |
| 2015 FY | 91.69 Million CNY | -3.26% |
| 2015 Q4 | 91.69 Million CNY | -35.85% |
| 2015 Q2 | 142.93 Million CNY | 50.81% |
| 2014 FY | 94.78 Million CNY | -12.24% |
| 2014 Q4 | 94.78 Million CNY | 0.0% |
| 2013 FY | 108 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -5954.92% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | 87.887% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -242.447% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | 10.545% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -84569.405% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -101.989% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -40.241% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -23.521% |
| PuraPharm Corporation Limited | 424.77 Million HKD | 2.926% |
| SSY Group Limited | 3.37 Billion HKD | 87.779% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -209.084% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | 44.976% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 99.52% |